⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Intellia Therapeutics, Inc

$11.28
+0.08 (+0.67%)

Volume:

2.051M ($23.09M)

Market Capitalization:

$1.58B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Intellia Therapeutics, Market Segments

After Hours

+0.02(+0.18%)
Open$11.26
Close$11.28
Low$11.10
Low Change-0.16 (-1.41%)
High$11.29
High Change+0.03 (+0.29%)
Range$0.19
Volume436.892K
Dollar Volume$4.93M

Regular Trading Hours

+0.02(+0.13%)
Open$11.24
Close$11.26
Low$11.09
Low Change-0.15 (-1.30%)
High$11.44
High Change+0.20 (+1.78%)
Range$0.35
Volume1.6M
Dollar Volume$18.01M

Premarket

+0.02(+0.18%)
Open$11.20
Close$11.22
Low$11.16
Low Change-0.04 (-0.36%)
High$11.34
High Change+0.14 (+1.25%)
Range$0.18
Volume13.545K
Dollar Volume$151.97K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.11(-0.98%)
Open$11.21
Close$11.10
Low$11.03
Low Change-0.18 (-1.61%)
High$11.27
High Change+0.06 (+0.54%)
Range$0.24
Volume756.143K
Dollar Volume$8.39M

Regular Trading Hours Yesterday

+0.21(+1.86%)
Open$11.00
Close$11.21
Low$10.58
Low Change-0.42 (-3.82%)
High$11.24
High Change+0.24 (+2.18%)
Range$0.66
Volume2.723M
Dollar Volume$30.51M

Premarket Yesterday

-0.19(-1.70%)
Open$11.19
Close$11.00
Low$11.00
Low Change-0.19 (-1.70%)
High$11.19
High Change+0.00 (+0.00%)
Range$0.19
Volume10.124K
Dollar Volume$111.36K

Intellia Therapeutics, News

There is no current news for this stock at the moment.

Intellia Therapeutics, Top Trades

Intellia Therapeutics,'s top trade so far today returned +2.51%, while the top short trade returned -2.96%.

Intellia Therapeutics, Moving Averages

5 Day Moving Average (SMA5)$11.48
10 Day Moving Average (SMA10)$11.61
20 Day Moving Average (SMA20)$11.93
50 Day Moving Average (SMA50)$12.21
100 Day Moving Average (SMA100)$12.81
200 Day Moving Average (SMA200)$13.05

Intellia Therapeutics, Statistics

Average Volume (30 Days)4.94M
P/E Ratio (Current)-4.59
EPS (Current)-$2.85
Dividend Yield0.00%
Free Cash Flow-$348.69M
Cash Ratio1.34
Current Ratio6.65
Quick Ratio6.65
Debt to Equity0.00
Enterprise Value$1.73B
EV to EBITDA-4.16
EV to Sales28.99
Price to Book2.52
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales30.78
Return on Assets-0.47%
Return on Equity-0.55%

Intellia Therapeutics, Stock Splits

There have been no stock splits for Intellia Therapeutics, (NTLA).

Intellia Therapeutics, Dividends

There have been no dividends for Intellia Therapeutics, (NTLA).